Abstract
It is clear that mature human articular cartilage does not have the innate ability to regenerate. Due to this, much effort has been put forth to work on bestowing this ability. While early data focused on more basic outcomes such as percentage of defect fill, the tissue formed was a “cartilage scar” or “hyaline-like” tissue. Even with more advanced technologies, it is clear that no current procedure is able to reconstitute the native structure and function of true hyaline cartilage. As research advancement has somewhat plateaued in this regard, it is crucial that future work focuses on a multifactorial approach, treating the joint as an organ system. The purpose of this review is to update readers on the most recent literature and controversies surrounding articular cartilage regeneration. Specific focus will be placed on current technologies available in the USA and the basic science to support them.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Papadopoulou AK, Papachristou DJ, Chatzopoulos SA, Pirttiniemi P, Papavassiliou AG, Basdra EK. Load application induces changes in the expression levels of Sox-9, FGFR-3 and VEGF in condylar chondrocytes. FEBS Lett. 2007;581:2041–6.
Salter RB, Field P. The effects of continuous compression on living articular cartilage an experimental investigation. J Bone Joint Surg Am. 1960;42:31–90.
Freyria A-M, Mallein-Gerin F. Chondrocytes or adult stem cells for cartilage repair: the indisputable role of growth factors. Injury. 2012;43(3):259–65.
Frisbie DD, Morisset S, Ho CP, Rodkey W, Steadman RJ, McIlwraith CW. Effects of calcified cartilage on healing of chondral defects treated with microfracture in horses. Am J Sports Med. 2006;34:1824–31.
Goyal D, Keyhani S, Lee EH, Hui JHP. Evidence-based status of microfracture technique: a systematic review of level I and II studies. Arthroscopy. 2013;29:1579–88.
Mithoefer K, McAdams T, Williams RJ, Kreuz PC, Mandelbaum BR. Clinical efficacy of the microfracture technique for articular cartilage repair in the knee: an evidence-based systematic analysis. Am J Sports Med. 2009;37:2053–63. This is a key article for understanding which patients will benefit from microfracture.
Kreuz P, Steinwachs M, Erggelet C, KRAUSE S, KONRAD G, UHL M, et al. Results after microfracture of full-thickness chondral defects in different compartments in the knee1. Osteoarthritis Cartilage. 2006;14:1119–25.
Negrin L, Kutscha-Lissberg F, Gartlehner G, Vécsei V. Clinical outcome after microfracture of the knee: a meta-analysis of before/after-data of controlled studies. Int Orthop. 2012;36:43–50.
Gudas R, Kalesinskas RJ, Kimtys V, Stankevicius E, Toliusis V, Bernotavicius G, et al. A prospective randomized clinical study of mosaic osteochondral autologous transplantation versus microfracture for the treatment of osteochondral defects in the knee joint in young athletes. Arthroscopy. 2005;21:1066–75.
Minas T, Gomoll AH, Rosenberger R, Royce RO, Bryant T. Increased failure rate of autologous chondrocyte implantation after previous treatment with marrow stimulation techniques. Am J Sports Med. 2009;37:902–8. This is currently a controversial topic, but spurs the question as to whether performing microfracture may burn a bridge to future treatment.
Pestka JM, Niemeyer P, Bode G, Salzmann G, Südkamp NP. Clinical outcome of autologous chondrocyte implantation for failed microfracture treatment of full-thickness cartilage defects of the knee joint. Am J Sports Med. 2012;40:325–31.
McNickle AG, Cole BJ, L’Heureux DR, Yanke AB. Outcomes of autologous chondrocyte implantation in a diverse patient population. Am J Sports Med. 2009;37:1344–50.
Chen H, Buschmann MD, Hoemann CD, Sun J, Chevrier A, McKee MD, et al. Depth of subchondral perforation influences the outcome of bone marrow stimulation cartilage repair. J Orthop Res. 2011;29:1178–84.
Franssen B, van Diest PJ, Schuurman AH, Kon M. Keeping osteocytes alive: a comparison of drilling and hammering K-wires into bone. J Hand Surg Eur Vol. 2008;33(3):363–8.
Stanish WD, McCormack R, Forriol F, Mohtadi N, Pelet S, Desnoyers J, et al. Novel scaffold-based BST-CarGel treatment results in superior cartilage repair compared with microfracture in a randomized controlled trial. J Bone Joint Surg Am. 2013;95:1640–50.
McCormick F, Cole BJ, Yanke AB, Provencher MT. Minced articular cartilage—basic science, surgical technique, and clinical application. Sports Med Arthrosc. 2008;16:217–20.
Adkisson HD, Martin JA, Amendola RL, Milliman C, Mauch KA, Katwal AB, et al. The potential of human allogeneic juvenile chondrocytes for restoration of articular cartilage. Am J Sports Med. 2010;38:1324–33.
Bonasia DE, Martin JA, Marmotti A, Amendola RL, Buckwalter JA, Rossi R, et al. Cocultures of adult and juvenile chondrocytes compared with adult and juvenile chondral fragments: in vitro matrix production. Am J Sports Med. 2011;39:2355–61.
Tompkins M, Hamann JC, Diduch DR, Bonner KF, Hart JM, Gwathmey FW, et al. Preliminary results of a novel single-stage cartilage restoration technique: particulated juvenile articular cartilage allograft for chondral defects of the patella. Arthroscopy. 2013;29:1661–70.
Farr J, Tabet SK, Margerrison E, Cole BJ. Clinical, radiographic, and histological outcomes after cartilage repair with particulated juvenile articular cartilage: a 2-year prospective study. Am J Sports Med. 2014;0363546514528671. Dr. Farr has been pioneer in using minced juvenile cartilage, and his group will continue to put out what is likely the most current data on this topic.
Chubinskaya S, Wepking K, Hakimiyan A, Margulis A, Rappoport L, Cole BJ. In vitro evaluation of minced adult and juvenile articular cartilage: a time course analysis. Izmir: International Cartilage Repair Society; 2013.
Lu Y, Cole BJ, Dhanaraj S, Wang Z, Bradley DM, Bowman SM, et al. Minced cartilage without cell culture serves as an effective intraoperative cell source for cartilage repair. J Orthop Res. 2006;24:1261–70.
Frisbie DD, Lu Y, Kawcak CE, DiCarlo EF, Binette F, McIlwraith CW. In vivo evaluation of autologous cartilage fragment-loaded scaffolds implanted into equine articular defects and compared with autologous chondrocyte implantation. Am J Sports Med. 2009;37 Suppl 1:71S–80.
Cole BJ, Farr J, Winalski CS, Hosea T, Richmond J, Mandelbaum B, et al. Outcomes after a single-stage procedure for cell-based cartilage repair: a prospective clinical safety trial with 2-year follow-up. Am J Sports Med. 2011;39:1170–9.
Kreuz PC, Steinwachs M, Erggelet C, Krause SJ, Ossendorf C, Maier D, et al. Classification of graft hypertrophy after autologous chondrocyte implantation of full-thickness chondral defects in the knee. Osteoarthr Cartil. 2007;15:1339–47.
Moradi B, Schönit E, Nierhoff C, Hagmann S, Oberle D, Gotterbarm T, et al. First-generation autologous chondrocyte implantation in patients with cartilage defects of the knee: 7 to 14 years’ clinical and magnetic resonance imaging follow-up evaluation. Arthroscopy. 2012;28:1851–61.
Minas T, Keudell Von A, Bryant T, Gomoll AH. The John Insall award: a minimum 10-year outcome study of autologous chondrocyte implantation. Clin Orthop Relat Res. 2013. This is a great paper to reinforce that for large, shallow defects, ACI is the technology to beat, not microfracture.
Vijayan S, Bartlett W, Bentley G, Carrington RWJ, Skinner JA, Pollock RC, et al. Autologous chondrocyte implantation for osteochondral lesions in the knee using a bilayer collagen membrane and bone graft: a two- to eight-year follow-up study. J Bone Joint Surg Br. 2012;94:488–92.
Chubinskaya S, Cole BJ, Hakimiyan AA, Rappoport L, Yanke AB, Rueger DC. Response of human chondrocytes prepared for autologous implantation to growth factors. J Knee Surg. 2008;21:192–9.
Van Assche D, Staes F, Van Caspel D, Vanlauwe J, Bellemans J, Saris DB, et al. Autologous chondrocyte implantation versus microfracture for knee cartilage injury: a prospective randomized trial, with 2-year follow-up. Knee Surg Sports Traumatol Arthrosc. 2010;18:486–95.
Knutsen G, Drogset JO, Engebretsen L, Grøntvedt T, Isaksen V, Ludvigsen TC, et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am. 2007;89:2105–12.
Lee KBL, Hui JHP, Song IC, Ardany L, Lee EH. Injectable mesenchymal stem cell therapy for large cartilage defects–a porcine model. Stem Cells. 2007;25:2964–71.
Chen FH, Tuan RS. Mesenchymal stem cells in arthritic diseases. Arthritis Res Ther. 2008;10:223.
Schnabel LV, Mohammed HO, Miller BJ, McDermott WG, Jacobson MS, Santangelo KS, et al. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res. 2007;25:230–40.
McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009;27:1033–42.
Fortier LA, Potter HG, Rickey EJ, Schnabel LV, Foo LF, Chong LR, et al. Concentrated bone marrow aspirate improves full-thickness cartilage repair compared with microfracture in the equine model. J Bone Joint Surg Am. 2010;92:1927–37. This is one of the most well performed microfracture augmentation sutdies done in an equine model. Adding beneficial growth factors to current cartilage technology will likely be a common occurrence in the future.
Liu Y, Shu XZ, Prestwich GD. Osteochondral defect repair with autologous bone marrow-derived mesenchymal stem cells in an injectable, in situ, cross-linked synthetic extracellular matrix. Tissue Eng. 2006;12:3405–16.
Gigante A, Cecconi S, Calcagno S, Busilacchi A, Enea D. Arthroscopic knee cartilage repair with covered microfracture and bone marrow concentrate. Arthroscop Tech. 2012;1:e175–80.
Nejadnik H, Hui JH, Feng Choong EP, Tai B-C, Lee EH. Autologous bone marrow-derived mesenchymal stem cells versus autologous chondrocyte implantation: an observational cohort study. Am J Sports Med. 2010;38:1110–6. This work along with the work that uses adipose derived stem cells, suggests that single stage arthroscopic procedures may be possible in the future along with being less age dependent.
Yang S-E, Ha CW, Jung M, Jin H-J, Lee M, Song H, et al. Mesenchymal stem/progenitor cells developed in cultures from UC blood. Cytotherapy. 2004;6:476–86.
Kim J-Y. Application of human umbilical cord blood-derived mesenchymal stem cells in disease models. WJSC. 2010;2:34.
Hunter DJ, Pike MC, Jonas BL, Kissin E, Krop J, McAlindon T. Phase 1 safety and tolerability study of BMP-7 in symptomatic knee osteoarthritis. BMC Musculoskelet Disord. 2010;11:232.
Lohmander LS, Hellot S, Dreher D, Krantz EFW, Kruger DS, Guermazi A, et al. Intra-articular Sprifermin (recombinant human fibroblast growth factor 18) in knee osteoarthritis: randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 2014;n/a–n/a.
Moore EE, Bendele AM, Thompson DL, Littau A, Waggie KS, Reardon B, et al. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthr Cartil. 2005;13:623–31.
Leitner GC, Gruber R, Neumüller J, Wagner A, Kloimstein P, Höcker P, et al. Platelet content and growth factor release in platelet-rich plasma: a comparison of four different systems. Vox Sang. 2006;91:135–9.
Cole BJ, Boswell SG, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012;28:429–39. Studies such as this are important as new products arrive (PRP, ACS, etc.) as the combination of factors injected is important to understand. This also varies significantly based on the manufacturer and process utilized.
Yin Z, Yang X, Jiang Y, Xing L, Xu Y, Lu Y, et al. Platelet-rich plasma combined with agarose as a bioactive scaffold to enhance cartilage repair: an in vitro study. J Biomater Appl. 2014;28:1039–50.
Dold AP, Zywiel MG, Taylor DW, Dwyer T, Theodoropoulos J. Platelet-rich plasma in the management of articular cartilage pathology: a systematic review. Clin J Sport Med. 2014;24:31–43.
Mei-Dan O, Carmont MR, Laver L, Mann G, Maffulli N, Nyska M. Platelet-rich plasma or hyaluronate in the management of osteochondral lesions of the talus. Am J Sports Med. 2012;40:534–41.
Wehling P, Moser C, Frisbie D, McIlwraith CW, Kawcak CE, Krauspe R, et al. Autologous conditioned serum in the treatment of orthopedic diseases: the orthokine therapy. BioDrugs. 2007;21:323–32.
Frisbie DD, Kawcak CE, Werpy NM, Park RD, McIlwraith CW. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am J Vet Res. 2007;68:290–6.
Baltzer AWA, Moser C, Jansen SA, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthr Cartil. 2009;17:152–60. This is arguably the highest profile article that has been published on Orthokine. Keep an eye out for further publication on its contents and efficacy that are not sponsored by the supplier to minimize bias.
Rutgers M, Saris DBF, Dhert WJA, Creemers LB. Cytokine profile of autologous conditioned serum for treatment of osteoarthritis, in vitro effects on cartilage metabolism and intra-articular levels after injection. Arthritis Res Ther. 2010;12:R114.
Compliance with Ethics Guidelines
Conflict of Interest
Adam B. Yanke receives research support from Arthrex and NuTech companies.
Susan Chubinskaya reports grants from Rush University Ciba-Geigy Endowed Chair, grants from Joint restoration foundation, grants from Zimmer during the conduct of the study, grants from Cartiheal, and grants from Merrimackpharma, outside the submitted work.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Biological Adjuvants in Orthopedic Surgery
Rights and permissions
About this article
Cite this article
Yanke, A.B., Chubinskaya, S. The state of cartilage regeneration: current and future technologies. Curr Rev Musculoskelet Med 8, 1–8 (2015). https://doi.org/10.1007/s12178-014-9254-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12178-014-9254-7